TIS 0.00% 0.0¢ tissue therapies limited

a proper update , page-2

  1. 2,630 Posts.
    lightbulb Created with Sketch. 4
    There isn't much market moving news to report. The EU trials slipped a month or two due to severe weather, but unlike prior trials progressive results were to be replaced by a wait for the full trial's completion.

    Commercilaisation deals proved a tougher nut than anticipated - and that's about it.

    It's all about patience.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.